The Global Dialysis Market was valued at USD 116.1 Billion in 2023 and is estimated to reach USD 198.2 Billion by 2033, growing at a CAGR of 5.4 % from 2024 to 2033.
Scope of the market:
Dialysis is the treatment for people whose kidneys have failed. In Kidney failure, the blood does not filter as it should perform. Here the procedure of dialysis helps to remove waste products and excess fluid from the blood. This is referred to as renal placement therapy. Dialysis can be done in a dialysis centre, hospital, or home.
The Singapore Ministry of Health is looking to increase the uptake of peritoneal Dialysis (PD) to 30% among new dialysis patients by 2025. In Singapore, an average of 5.5 patients is diagnosed per day with End Stage Renal Disease, and also by 2035it is projected to have around one-quarter of the population who are expected to have chronic kidney disease.
Furthermore, the emerging economies in Asia-Pacific is showing significant growth opportunities in the Dialysis Market. Moreover, technological advancement results in high adoption, and unexploited markets in developing countries are offering opportunities in the dialysis market.
Economic Impact of Covid-19:
The analysis of the COVID-19 recovery trajectory provides an overview of the main strategies that industries are implementing to respond to and recover from the economic crisis. It also focuses on the post-pandemic and pre-pandemic era of the Global Dialysis Market through PEST analysis, SWOT, Quantitative and Qualitative analysis, Attractive analysis, and DROs. Innovations by market players and an increasing number of products will propel the growth of this market.
The number of patients increasing day by day, but the major restraining factors of the Dialysis Market are the risks and complications at occur during dialysis treatment. Hemodialysis may cause severe complications for the patient undergoing the treatment.
Key Players:
- Medtronics Plc
- Becton
- Baxter International
- Nipro Medical Corporation
- JMS Co Ltd
- Dialife SA
- B Braun SE
- Kimal
- DaVita Inc
- Asahi Kasei Medical Co., Ltd
- Diaverum Deutschland GmbH
- NxStage Medical Inc.,
- Satellite Healthcare Inc.
- Davita
- Fresenius Se and Co.Kgaa
- Angiodynamics Inc.
- Others
The above key players in the Global Dialysis Market can be changed according to the client’s requirements.
Moreover, the key players aim towards expansion, joint ventures, collaboration, mergers, and acquisitions to advance capabilities in the Dialysis Market.
Recent Developments in Global Dialysis Market.
2024 January: Diaverum has announced its entry in Greece, with 6 new clinics across the country. The company's ambition is to become the leading provider of integrated AI-enabled personalized dialysis care and a global hub for holiday dialysis treatment. Diaverum is positioned as the Third largest renal care provider in Greece.
Diaverum has acquired clinics of Alexia, Attiko, Nefrologiki, and Medifil are the leading renal care institutions. 170 health professionals serving more than 500 dialysis patients.
2023: Medtronic and DaVita launched Mozarc Medical aimed at introducing new solutions for patients with kidney failure. Mozarc Medical is a new company focused on innovative kidney health technologies that will improve the overall patient experience and increase access to global care
Global Dialysis Market Key Benefits:
- The report provides information regarding key drivers, restraints, and opportunities with impact analysis.
- Quantitative and Qualitative analysis of the current market.
- Estimations for the forecast period 2032.
- Historical data and forecast data.
- Recent developments and trends in the market.
- Market share of the market players, company profiles, SWOT analysis, and competitive landscape.
- Covid-19 Impact analysis
Global Dialysis Market Segmentation:
By Dialysis Type:
- Peritoneal Dialysis
- Haemodialysis
By Product & Services
- Consumables
- Catheters
- Concentrates
- Access Products
- Dialyzers
- Equipment
- Water Treatment Systems
- Dialysis Machine
- Others
- Services
- Chronic Dialysis
- Acute Dialysis
By End-User:
- In- centre Dialysis and Hospitals
- Home Dialysis
Based on Region:
Asia-Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia-Pacific
North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Europe
The rest of the World
Each of the market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and competitive analysis.
Research Scope:
Report Scope |
Details |
|
|
Base Year |
2023 |
Historical Years |
2019 to 2022 |
Forecast Years |
2024 to 2033 |
Market Size 2023 |
USD 116.1 BN |
Market Revenue 2033 |
USD 198.2 BN |
Growth Rate 2024- 2033 |
5.4 % |
Report Coverage |
Trends, SWOT Analysis, Competitive Landscape, DROs, Revenue Forecast, PEST Analysis. |
Segments Covered |
Dialysis Type, Product & Services, End-User, Region |
Companies Mentioned |
Medtronic’s Plc, Becton, Baxter International, Nipro Medical Corporation, JMS Co Ltd, Dialife SA, B Braun SE, Kimal, DaVita Inc, Asahi Kasei Medical Co., Ltd, Diaverum Deutschland GmbH, NxStage Medical Inc., Satellite Healthcare Inc., Davita, Fresenius Se and Co.Kgaa, Angiodynamics Inc. |
Customization |
Yes |
Regional Analysis:
North America dominates over other regions, high rise in hypertension and diabetes are the factors that are accelerating the market. According to the CDC, In the U.S. 35.5 million people develop chronic kidney disease. These rising cases of kidney disease are contributing to demand for the dialysis services. The rising incidence of coronavirus infection and renal failure are also boosting this market's growth.
Europe is anticipated to be the 2nd largest market. The rise in the geriatric population with renal conditions is propelling this market.
Asia-Pacific is anticipated to witness steady growth in the global dialysis market. Elderly growing population are rising prevalence of kidney disease and kidney disorders are contributing too. This rising incidence of Kidney dysfunction increases the demand for renal therapy that includes dialysis. Moreover, the change in lifestyle and high prevalence of conditions like diabetes and hypertension increase the need for effective dialysis treatment.
Lack of awareness and absence of symptoms contribute to delay which results in the burden of kidney failure increases, almost 210,000 new cases are diagnosed each year.
Key questions answered by this report.
- Top market players contributing to the revenue?
- Trending strategies by the players?
- Which region will be the leading one in the forecast period?
- Factors that drive the Global Dialysis Market?
- Which factors will affect the Global Dialysis Market?
- How Covid-19 pandemic impacted the growth of the Global Dialysis Market?
- Which Segment accounted for the Global Dialysis Market shares?
Interested in this report?
The Global Dialysis Market was valued at USD 116.1 Billion in 2023 and is estimated to reach USD 198.2 Billion by 2033, growing at a CAGR of 5.4 % from 2024 to 2033.
TOC